نتایج جستجو برای: anti hcv antibody

تعداد نتایج: 494407  

2011
Keane K.Y. Lai Ming Jin Shan Yuan Meaghan F. Larson Jason A. Dominitz Daniel D. Bankson

BACKGROUND: Chemiluminescence immunoassay (CIA) is used to detect hepatitis C virus (HCV) antibody status on the basis of signal-to-cutoff (S/Co) ratios. Positive results of antibody to HCV (anti-HCV) are followed by either recombinant immunoblot assay (RIBA) to confirm anti-HCV positivity or reverse transcription (RT)-PCR to detect viremia. We hypothesized that by analyzing S/Co ratios, we cou...

2015
Debasish Basu Arun Kumar Sharma Sunil Gupta Naresh Nebhinani Vineet Kumar

BACKGROUND & OBJECTIVES Injecting drug use is a major route of hepatitis C virus (HCV) infection in India, but there may be other risk factors also. This study was carried out to determine the seroprevalence of anti-HCV antibody in injecting drug users (IDUs) vs. non-IDUs (NIDUs), and to study the risk estimates for HCV seropositivity in the total sample of substance users with regard to variou...

Journal: :Journal of viral hepatitis 2016
L Poiteau A Soulier I Rosa F Roudot-Thoraval C Hézode J-M Pawlotsky S Chevaliez

Rapid diagnostic tests (RDTs) represent an attractive alternative to enzyme immunoassays. A total of 207 individuals, including 68 HCV-seronegative subjects, 10 patients with resolved infection and 129 patients with chronic HCV infection, were studied. The specificity of RDT detection of anti-HCV antibodies in whole blood was 100% with the four RDTs tested: OraQuick(®) HCV Rapid Antibody Test, ...

2013
Isabel Fofana Fei Xiao Christine Thumann Marine Turek Laetitia Zona Rajiv G. Tawar Fritz Grunert John Thompson Mirjam B. Zeisel Thomas F. Baumert

BACKGROUND AND AIMS Hepatitis C virus (HCV) infection is a challenge to prevent and treat because of the rapid development of drug resistance and escape. Viral entry is required for initiation, spread, and maintenance of infection, making it an attractive target for antiviral strategies. METHODS Using genetic immunization, we produced four monoclonal antibodies (mAbs) against the HCV host ent...

Journal: :jundishapur journal of microbiology 0
mishar kelishadi department of virology, golestan university of medical sciences, gorgan, ir iran mohammad mojerloo department of hemodialysis, azar hospital, gorgan, ir iran abdolvahab moradi department of virology, golestan university of medical sciences, gorgan, ir iran masoud bazouri department of virology, golestan university of medical sciences, gorgan, ir iran pezhman hashemi department of virology, golestan university of medical sciences, gorgan, ir iran sobhan samadi department of virology, golestan university of medical sciences, gorgan, ir iran

conclusions the current study found a relatively high frequency of positivity gbv-c-exposure among the patients receiving hemodialysis in the area understudy. nosocomial transmission seems to be the main route of gbv-c infection in the area. objectives the current study aimed to evaluate gbv-c infection among hemodialysis patients. patients and methods totally, 149 patients receiving hemodialys...

Journal: :Journal of Korean Medical Science 1999
Y. M. Park B. H. Byun J. Y. Choi S. H. Bae B. S. Kim H. S. So W. S. Ryu

To evaluate the clinical feasibility of the antibody titer against a chimeric polypeptide (named Core 518), in which a domain of Core and NS3 of hepatitis C virus (HCV) was fused, ELISA was performed in a total of 76 serum samples. Each serum was serially diluted using two-fold dilution method with distilled water into 10 concentrations. They were all positive for second generation anti-HCV ass...

Journal: :Clinical and vaccine immunology : CVI 2016
Shu Feng Bin Wei Qianqian Liu Tingting Wang Dongdong Li Chenli Rao Chuanmin Tao Lanlan Wang

The hepatitis C virus (HCV) antibody assay remains the first-line screening test to identify HCV infection. The newly arrived HISCL Anti-HCV assay had a satisfactory seroconversion sensitivity. Its sensitivity and specificity were 98.97 and 100% for clinical samples. In general, the HISCL Anti-HCV assay may be a novel choice for clinical HCV screening.

Journal: :jundishapur journal of microbiology 0
fahimeh ranjbar kermani blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran zohreh sharifi blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran; blood transfusion research center, high institute for research and education in transfusion medicine, p.o. box: 14665-1157, tehran, ir iran. tel/fax: +98-218860150130 fereshteh ferdowsian blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran zahrah paz blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran farzaneh tavassoli blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran

objectives the current study aimed to assess relationship between s/co rates and hcv-rna levels in the laboratory to identify hcv viremia in patients with a positive anti-hcv. patients and methods all serum samples were assayed for anti-hcv by elisa method. a total of 265 anti-hcv positive patients were tested for hcv-rna testing by quantitative method using artus hcv rg real-time polymerase ch...

2011
Alexander M Strasak Arthur Y Kim Georg M Lauer Paulo S de Sousa Cleber F Ginuino Carlos A Fernandes Carlos E Velloso Adilson J de Almeida Jaqueline M de Oliveira Clara F Yoshida Julian Schulze zur Wiesch Gláucia Paranhos-Baccalá Stefan Lang Larry J Brant Hanno Ulmer Susanne Strohmaier Lalit Kaltenbach Elisabeth Lampe Lia L Lewis-Ximenez

BACKGROUND The anti-HCV antibody response has not been well characterized during the early phase of HCV infection and little is known about its relationship to the clinical course during this period. METHODS We analyzed serial anti-HCV antibodies longitudinally obtained from a prospective cohort of 65 patients with acute HCV infection by using a microparticle enzyme immunoassay AxSYM HCV 3.0 ...

Journal: :American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005
Fabrizio Fabrizi Paul Martin Vivek Dixit Suphamai Bunnapradist Gareth Dulai

The natural history of hepatitis C virus (HCV) among patients after renal transplantation (RT) remains incompletely defined. We conducted a systematic review of the published medical literature on the impact of hepatitis C antibody status on survival of patients who received RT. We used the random effects model of DerSimonian and Laird to generate a summary estimate of the relative risk (RR) fo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید